Skip to content
DraconiticResearch
Search Sources API
190,851 studies31 sourcesUpdated 47 min ago
Peer-reviewedLicence not statedDrug and alcohol dependence

Trajectories of insomnia and anhedonia during early substance use treatment across opioid, stimulant, and opioid–stimulant co-use

  • Tanya Pareek1
  • I-Tzu Hung2,3
  • Ariel Hoadley1
  • J. Gregory Hobelmann4
  • Taylor D. Parnham1
  • Jill A. Rabinowitz2,3
  • Andrew S. Huhn1,4
4 affiliations
  1. 1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224
  2. 2Department of Psychiatry, Robert Wood Johnson Medical Center, Rutgers University, Piscataway, NJ 08854
  3. 3Rutgers Addiction Center, Brain Health Institute, Rutgers University, Piscataway, NJ 08854
  4. 4Ashley Addiction Treatment, Havre de Grace, MD 21078
Read full textDOICite

Related

  1. Performance in play: stimulant exposure and broader substance-use vulnerability in mass-participation youth esports.
    Rui-Yan Sun, Si-Yuan Zhao
    Frontiers in public healthPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMCCrossref
  2. Postpartum contraception receipt among Oregon Medicaid-funded births with stimulant and substance use disorder.
    Stephan R Lindner, Menolly Kaufman, Ann Martinez Acevedo +1
    Reproductive healthPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCDOAJ
  3. Three-year trajectories of insomnia symptoms among young breast cancer survivors
    Chloe M. Hery, Kayla Williams, Sarah A. Janse +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  4. Commentary: The “efficacy window” phenomenon of daridorexant in insomnia treatment: a dose-dependent time-course meta-analysis
    William V. McCall, Neil A. Burton, Björn Steiniger-Brach
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
  5. Medical cannabis for the treatment of insomnia
    Lucia B Varela, Joselyn Elizabeth Miño Zambrano, Brenda Maura Goncalves Costa +5
    The Cochrane Database of Systematic ReviewsPeer-reviewedPublisher termsFull textPharmacology & toxicologyPMC

Cite

BibTeXRIS
BibTeX
@article{pareek2026trajectories,
  title = {{Trajectories of insomnia and anhedonia during early substance use treatment across opioid, stimulant, and opioid–stimulant co-use}},
  author = {Tanya Pareek and I-Tzu Hung and Ariel Hoadley and J. Gregory Hobelmann and Taylor D. Parnham and Jill A. Rabinowitz and Andrew S. Huhn},
  journal = {Drug and alcohol dependence},
  year = {2026},
  month = sep,
  doi = {10.1016/j.drugalcdep.2026.113364},
  url = {https://doi.org/10.1016/j.drugalcdep.2026.113364},
}
RIS
TY  - JOUR
TI  - Trajectories of insomnia and anhedonia during early substance use treatment across opioid, stimulant, and opioid–stimulant co-use
AU  - Tanya Pareek
AU  - I-Tzu Hung
AU  - Ariel Hoadley
AU  - J. Gregory Hobelmann
AU  - Taylor D. Parnham
AU  - Jill A. Rabinowitz
AU  - Andrew S. Huhn
PY  - 2026
DA  - 2026/09/11
JO  - Drug and alcohol dependence
DO  - 10.1016/j.drugalcdep.2026.113364
UR  - https://doi.org/10.1016/j.drugalcdep.2026.113364
SN  - 0376-8716
SN  - 1879-0046
ER  -